• Explore /
  • Poster
  • / Intergroup phase III trial of neo-adjuvant chemotherapy, followed by chemoradiation and surgery with and without cetuximab in locally advanced esophageal carcinoma: First results from the SAKK 75/08 trial.

Intergroup phase III trial of neo-adjuvant chemotherapy, followed by chemoradiation and surgery with and without cetuximab in locally advanced esophageal carcinoma: First results from the SAKK 75/08 trial.

Abstract Poster

Authors

Thomas Ruhstaller

Thomas Ruhstaller

Kantonsspital, St. Gallen, Switzerland

Thomas Ruhstaller , Peter C. Thuss-Patience , Stefanie Hayoz , Sabina Schacher-Kaufmann , Jorge Riera-Knorrenschild , Annelies Schnider , Ludwig Plasswilm , Wilfried Budach , Wolfgang Eisterer , Hanne Hawle , Christophe Mariette , Viviane Hess , Walter B. Mingrone , Anna Dorothea Wagner , Michael Girschikofsky , Sven-Christian Schmidt , Michael Bitzer , Laurent Bedenne , Peter Brauchli , Michael Stahl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT01107639

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4019)

DOI

10.1200/JCO.2017.35.15_suppl.4019

Abstract #

4019

Poster Bd #

11

Abstract Disclosures

Similar Posters

First Author: Yoojoo Lim

First Author: Satoru Matsuda

First Author: Winston Wong

First Author: Ajaykumar Singh